These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37353384)

  • 1. Retraction notice to: "LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p" [Biomed. Pharmacother. 122 (2019) 109707].
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2023 Oct; 166():114876. PubMed ID: 37353384
    [No Abstract]   [Full Text] [Related]  

  • 2. RETRACTED: LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p.
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2020 Feb; 122():109707. PubMed ID: 31918278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12.
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression.
    Tao W; Wang C; Zhu B; Zhang G; Pang D
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 7. Long non-coding RNA DANCR regulates proliferation and apoptosis of chondrocytes in osteoarthritis via miR-216a-5p-JAK2-STAT3 axis.
    Zhang L; Zhang P; Sun X; Zhou L; Zhao J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2023 Aug; 164():114728. PubMed ID: 37087341
    [No Abstract]   [Full Text] [Related]  

  • 9. A review on the role of DANCR in the carcinogenesis.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Samadian M
    Cancer Cell Int; 2022 May; 22(1):194. PubMed ID: 35590326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition.
    Jiang N; Wang X; Xie X; Liao Y; Liu N; Liu J; Miao N; Shen J; Peng T
    Cancer Lett; 2017 Oct; 405():46-55. PubMed ID: 28642170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction notice to "LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p" [Biomed. Pharmacother. 114 (2019) 108862].
    Liu S; Zhang W; Liu K; Liu Y
    Biomed Pharmacother; 2024 Feb; 171():116188. PubMed ID: 38296726
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].
    Hu C; Liu S; Han M; Wang Y; Xu C
    Biomed Pharmacother; 2022 May; 149():112795. PubMed ID: 35282972
    [No Abstract]   [Full Text] [Related]  

  • 14. Upregulation of lncRNA DANCR functions as an oncogenic role in non-small lung cancer by regulating miR-214-5p/CIZ1 axis.
    Chen YR; Wu YS; Wang WS; Zhang JS; Wu QG
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2539-2547. PubMed ID: 32196604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
    Wang K; Yang C; Shi J; Gao T
    Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DANCR sponges miR-216a to inhibit odontoblast differentiation through upregulating c-Cbl.
    Chen L; Song Z; Wu J; Huang Q; Shen Z; Wei X; Lin Z
    Exp Cell Res; 2020 Feb; 387(1):111751. PubMed ID: 31805275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction notice to "Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p" [Biomed. Pharmacother. 117 (2019) 109153].
    Xu C; Hu C; Wang Y; Liu S
    Biomed Pharmacother; 2022 Jun; 150():112857. PubMed ID: 35341639
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.
    Wen D; Li S; Jiang W; Zhao S; Liu J; Zhu J
    Biomed Pharmacother; 2023 Oct; 166():114877. PubMed ID: 37353385
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice for: "lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy" [https://doi.org/10.1590/1414-431X20209288].
    Braz J Med Biol Res; 2023 May; 56():e9288retraction. PubMed ID: 37194836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction notice to "Inhibition of miR-31a-5p decreases inflammation by down-regulating IL-25 expression in human dermal fibroblast cells (CC-2511 cells) under hyperthermic stress via Wnt/β-catenin pathway" [Biomed. Pharmacother. 107 (2018) 24-33].
    Jiang L; Xue W; Wang Y
    Biomed Pharmacother; 2021 Oct; 142():112129. PubMed ID: 34507835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.